4.7 Article

Anal Cancer Screening and Prevention: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Guidelines

Journal

CLINICAL INFECTIOUS DISEASES
Volume 74, Issue SUPPL 2, Pages S179-S192

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciac044

Keywords

human papillomavirus (HPV); anal dysplasia; anal cancer; high resolution anoscopy; human immunodeficiency virus (HIV)

Ask authors/readers for more resources

This article summarizes the key questions, evidence, recommendations, and areas for further research in the screening, diagnosis, and prevention of anal cancer as discussed by the advisory group convened by CDC in June 2019.
In June 2019 the Centers for Disease Control and Prevention (CDC) convened an advisory group to assist in development of the 2021 CDC sexually transmitted infections (STI) guidelines. The advisory group on anal cancer screening and prevention met to formulate key questions in this field. The group examined published literature and abstracts to assess evidence and give recommendations for development of the CDC guidelines. This article summarizes key questions, evidence, recommendations, and areas for further research for the screening, diagnosis, and prevention of anal cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available